A Phase III Study of MP-513 in Combination With Thiazolidinedione in Japanese Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2013
At a glance
- Drugs Teneligliptin (Primary) ; Thiazolidinediones
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 26 Aug 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 26 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.